Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial
Conclusions Aspirin use at baseline was associated with an increased risk for bleeding and all-cause death in ROCKET AF, a risk most pronounced in patients without known CAD. Although these findings may reflect unmeasured clinical factors, further investigation is warranted to determine optimal aspirin use in patients with AF.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Coumadin | Heart | Heart Attack | Heart Failure | Stroke | Vitamins | Warfarin